ARMP SG&A Expense Growth
Armata Pharmaceuticals, Inc. Common Stock · SG&A Expense Growth
ARMP SG&A Expense Growth
Latest reported-5.88%period ending
ARMP FY SG&A Growth (YoY) (0.00% → -5.88%)
Latest values, visible window
High-resolution chart · PNG
ARMP sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -5.8783% | |
| 23.4804% | |
| 43.566% | |
| -10.192% | |
| 3.9543% | |
| 0.6571% | |
| 38.7934% | |
| -24.8748% | |
| -9.7825% | |
| 31.0232% | |
| -6.2628% | |
| 14.2428% | |
| 86.9077% | |
| 0% | |
| -100% | |
| -17.1717% | |
| 10.1379% | |
| 1.093% | |
| -5.0677% | |
| 21.1293% | |
| -31.945% | |
| 30.05% | |
| 8.672% | |
| 58.5556% | |
| 20% | |
| 7.1429% | |
| -3.4483% | |
| 26.087% | |
| 21.0526% | |
| -65.4545% | |
| 0% |